Natural Killer (NK) Cell Therapeutics Market Trends Report 2025 – For Business Development and Strategy Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Natural Killer (NK) Cell Therapeutics Market Growth in 2025?
There has been substantial growth in the market size of natural killer (NK) cell therapeutics in the past few years. The market is set to expand from $3.52 billion in 2024 to $3.96 billion in 2025, representing a compound annual growth rate (CAGR) of 12.6%. This significant growth during the historic period can be linked to factors such as the increasing incidence of cancer, augmented research and development funding, enhanced awareness of immunotherapy, increased strategic collaborations within the industry, increased regulatory support, and advancements in cell expansion technologies.
What Is the Forecast for the Natural Killer (NK) Cell Therapeutics Market Size Through 2029?
In the coming years, the commercial landscape for natural killer (NK) cell therapeutics is projected to witness accelerated expansion. The market is estimated to reach a value of $6.3 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.3%. Factors like an increase in clinical trials, investment surge in immunotherapy research and development, extending uses in solid tumors, various strategic partnerships, regulatory backing for cell-based therapies, and heightened demand for individualized cancer treatment are seen as the main drivers for this growth. Future trends that are anticipated to influence the market dynamics include advancements in genetic engineering, betterment of CAR-NK therapies, enhanced cell multiplication methodologies, innovations in clinical trial activities, production of ready-to-use NK cell products, and progress in solid tumor therapeutic approaches.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24328&type=smp
What are the Key Market Players in Natural Killer (NK) Cell Therapeutics Market and How They’re Evolving?
Major companies operating in the natural killer (NK) cell therapeutics market are Sanofi S.A., Thermo Fisher Scientific, Lonza AG, Catalent, Kite Pharma, Fate Therapeutics, Artiva Biotherapeutics, Nkarta, Inc, Celularity Inc., NKGen Biotech, Dragonfly Therapeutics, Cytovia Therapeutics, Glycostem Therapeutics, Gamida Cell, ONK Therapeutics, Wugen Inc., AGC Biologics, CytoImmune Therapeutics, XNK Therapeutics, Indapta Therapeutics, Neukio Biotherapeutics, Senti Biosciences, WuXi Advanced Therapies, Kiadis Pharma
What Are the Primary Growth Drivers in the Natural Killer (NK) Cell Therapeutics Market?
The escalating occurrence of cancer is anticipated to drive the growth of the natural killer (NK) cell therapeutics market. Cancer, a disease where abnormal cells multiply uncontrollably, can harm neighboring tissues and metastasize to other areas of the body. This disorder interferes with regular cell regulation, generating tumors and undermining bodily functions. Factors like exposure to pollutants, tobacco smoke, and chemicals can impair DNA and interfere with cellular functions, leading to an elevated risk of cancer. Natural killer (NK) cell therapeutics effectively combat cancer by explicitly targeting and eliminating cancerous cells without any prior sensitization. As per a report in April 2024 by the American Cancer Society, a non-profit organization based in the US, 20 million new cancer cases surfaced and 9.7 million fatalities were recorded globally in 2022. Projections based on population growth indicate that the number of cancer cases could soar to 35 million by 2050. Thus, the increasing prevalence of cancer is positively impacting the growth of the natural killer (NK) cell therapeutics market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24328&type=smp
What Are the Leading Segments in the Global Natural Killer (NK) Cell Therapeutics Industry?
The natural killer (NK) cell therapeutics market covered in this report is segmented –
1) By Therapeutics: Natural Killer (NK) Cell Directed Antibodies, Natural Killer (NK) Cell Therapies
2) By Application: Immunoproliferative Disorders, Gastrointestinal Diseases, Cancer, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Direct Tender, Other Distribution Channels
4) By End User: Research And Academic Institutes, Hospitals, Specialty Clinics
Subsegments:
1) By Natural Killer (NK) Cell Directed Antibodies: Monoclonal Antibodies (mAbs), Bispecific Antibodies (BsAbs), Antibody-Drug Conjugates (ADCs)
2) By Natural Killer (NK) Cell Therapies: Autologous NK Cell Therapies, Allogeneic NK Cell Therapies, Chimeric Antigen Receptor (CAR)-NK Cell Therapies
What Are the Key Market Trends in the Natural Killer (NK) Cell Therapeutics Industry?
Prominent players in the natural killer (NK) cell therapeutics industry are prioritizing innovations such as the establishment of scalable, iPSC-based NK cell production platforms to make NK cell therapy more affordable and readily available. These platforms use induced pluripotent stem cells (iPSCs) as the basis for producing NK cells in a homogenized, feeder-free, and closed-system bioreactor landscape, which ensures high yields and adherence to regulations. For example, in April 2025, the Belgian biotech research firm Cellistic introduced the Echo-NK platform, an iPSC-oriented manufacturing solution for NK cell therapies. This platform facilitates the expandable production of NK cells aimed at blood cancers, solid tumors, and autoimmune diseases, performing all critical expansion steps in bioreactor closed systems located in Cellistic’s EMA-approved GMP facility. By combining the firm’s Pulse cell line development capabilities and patented STAR-CRISPR technology with the Echo-NK platform, the development of stable iPSC cell lines with specific gene edits can be expedited, providing a commercially feasible option for off-the-shelf NK cell therapies.
Access The Full Report Here:
What Is the Regional Outlook for the Natural Killer (NK) Cell Therapeutics Market?
North America was the largest region in the natural killer (NK) cell therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the natural killer (NK) cell therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/customise?id=24328&type=smp
This Report Delivers Insight On:
1. How big is the natural killer (nk) cell therapeutics market, and how is it changing globally?
2. Who are the major companies in the natural killer (nk) cell therapeutics market, and how are they performing?
3. What are the key opportunities and risks in the natural killer (nk) cell therapeutics market right now?
4. Which products or customer segments are growing the most in the natural killer (nk) cell therapeutics market?
5. What factors are helping or slowing down the growth of the natural killer (nk) cell therapeutics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
